share_log

Short Interest in Exela Technologies, Inc. (NASDAQ:XELAP) Expands By 46.5%

Defense World ·  Dec 13, 2022 01:41

Exela Technologies, Inc. (NASDAQ:XELAP – Get Rating) was the target of a significant increase in short interest in November. As of November 30th, there was short interest totalling 14,500 shares, an increase of 46.5% from the November 15th total of 9,900 shares. Based on an average trading volume of 5,800 shares, the short-interest ratio is currently 2.5 days.

Exela Technologies Stock Performance

Shares of NASDAQ:XELAP opened at $3.23 on Tuesday. The business has a 50 day moving average price of $3.94. Exela Technologies has a 52-week low of $3.02 and a 52-week high of $12.50.

Get Exela Technologies alerts:

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in XELAP. UBS Group AG lifted its holdings in shares of Exela Technologies by 1,829.9% in the third quarter. UBS Group AG now owns 9,437 shares of the company's stock valued at $46,000 after purchasing an additional 8,948 shares in the last quarter. Cantor Fitzgerald L. P. bought a new position in shares of Exela Technologies in the third quarter valued at approximately $733,000. Finally, BlackRock Inc. lifted its holdings in shares of Exela Technologies by 60.8% in the third quarter. BlackRock Inc. now owns 232,101 shares of the company's stock valued at $1,126,000 after purchasing an additional 87,804 shares in the last quarter.

About Exela Technologies

(Get Rating)

Exela Technologies, Inc provides transaction processing solutions, enterprise information management, document management, and digital business process services worldwide. The company operates through three segments: Information & Transaction Processing Solutions (ITPS), Healthcare Solutions (HS), and Legal & Loss Prevention Services (LLPS).

Featured Stories

  • Get a free copy of the StockNews.com research report on Exela Technologies (XELAP)
  • Coinbase Global Stock is a Falling Meat Cleaver
  • It's Still Too Soon to Shop for Kohl's Stock
  • Three Small-Cap Biotech Stocks to Consider Now
  • Two Blue Chip Health Companies The Institutions Are Buying
  • What To Expect From The Q4 Earnings Reporting Season

Receive News & Ratings for Exela Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exela Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment